Overview

Clinical Trial to Evaluate the Efficacy and Safety of LEVI-04 in Patients With Osteoarthritis of the Knee

Status:
Recruiting
Trial end date:
2023-12-12
Target enrollment:
Participant gender:
Summary
This is a phase 2, randomized, double-blind, placebo-controlled trial of multiple doses and multiple administrations of LEVI-04 for the treatment of pain due to osteoarthritis of the knee.
Phase:
Phase 2
Details
Lead Sponsor:
Levicept
Collaborator:
Nordic Bioscience Clinical Development (NBCD)